115 related articles for article (PubMed ID: 33194849)
1. LncRNA NCK1-AS1 in plasma distinguishes oral ulcer from early-stage oral squamous cell carcinoma.
Le F; Ou Y; Luo P; Zhong X
J Biol Res (Thessalon); 2020 Dec; 27():16. PubMed ID: 33194849
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of lncRNA NCK1-AS1 Inhibits Cancer Cell Migration and Invasion in Nasopharyngeal Carcinoma by Upregulating miR-135a.
Hu H; Li H; Feng X
Cancer Manag Res; 2019; 11():10531-10537. PubMed ID: 31908525
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA NCK1-AS1 promotes the proliferation, migration and invasion of non-small cell lung cancer cells by acting as a ceRNA of miR-137.
Li J; Wu X; Cao W; Zhao J
Am J Transl Res; 2020; 12(10):6908-6920. PubMed ID: 33194081
[TBL] [Abstract][Full Text] [Related]
4. Altered expression of lncRNA NCK1-AS1 distinguished patients with prostate cancer from those with benign prostatic hyperplasia.
Guan Z; Song Y; Ma J; Li F; Zhao X; Liang G; An H; Pu J
Oncol Lett; 2019 Dec; 18(6):6379-6384. PubMed ID: 31807161
[TBL] [Abstract][Full Text] [Related]
5. LncRNA NCK1-AS1 promotes non-small cell lung cancer progression via regulating miR-512-5p/p21 axis.
Luo X; Zhou J; Quan L; Liang Y; Huang P; Chen F; Liu S
Pathol Res Pract; 2020 Nov; 216(11):153157. PubMed ID: 32858372
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of lncRNA FEZF1-AS1 in promoting the occurrence and development of oral squamous cell carcinoma through targeting miR-196a.
Xu L; Hou TJ; Yang P
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6505-6515. PubMed ID: 31378890
[TBL] [Abstract][Full Text] [Related]
7. lncRNA MCM3AP-AS1 promotes the development of oral squamous cell carcinoma by inhibiting miR-363-5p.
Hou C; Wang X; Du B
Exp Ther Med; 2020 Aug; 20(2):978-984. PubMed ID: 32742341
[TBL] [Abstract][Full Text] [Related]
8. Knockdown Of lncRNA NCK-AS1 Regulates Cisplatin Resistance Through Modulating miR-137 In Osteosarcoma Cells.
Cheng Y; Shen X; Zheng M; Zou G; Shen Y
Onco Targets Ther; 2019; 12():11057-11068. PubMed ID: 31908475
[TBL] [Abstract][Full Text] [Related]
9. LncRNA NCK1-AS1 Promotes Cancer Cell Proliferation and Increase Cell Stemness in Urinary Bladder Cancer Patients by Downregulating miR-143.
Qiao Z; Dai H; Zhang Y; Li Q; Zhao M; Yue T
Cancer Manag Res; 2020; 12():1661-1668. PubMed ID: 32184669
[TBL] [Abstract][Full Text] [Related]
10. LncRNA INHBA-AS1 promotes cell growth, migration, and invasion of oral squamous cell carcinoma by sponging miR-143-3p.
Ma WQ; Chen J; Fang W; Yang XQ; Zhu A; Zhang D; Zhong HL; Yang B; Luo Z
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1821-1828. PubMed ID: 32141551
[TBL] [Abstract][Full Text] [Related]
11. NCK1-AS1 promotes the progression of melanoma by accelerating cell proliferation and migration via targeting miR-526b-5p/ADAM15 axis.
Lin Q; Jia Y; Zhang D; Jin H
Cancer Cell Int; 2021 Jul; 21(1):367. PubMed ID: 34247598
[TBL] [Abstract][Full Text] [Related]
12. COX10-AS1-mediated miR-361-5p regulated cell invasion and migration by targeting SPRY1 in oral squamous cell carcinoma.
Deng J; Wu M
Am J Transl Res; 2023; 15(3):2191-2206. PubMed ID: 37056821
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA PSMG3 Antisense RNA 1 is correlated with oral squamous cell carcinoma and regulates cancer cell proliferation by targeting premature microRNA-141.
Ouyang S; Xuan F; Zhang X; Yuan W; Fan X; Wang J
Am J Cancer Res; 2023; 13(1):227-235. PubMed ID: 36777518
[TBL] [Abstract][Full Text] [Related]
14. lncRNA TMEM161B-AS1 screened the onset of oral squamous cell carcinoma in HPV-infected patients, predicted poor prognosis, and regulated cell progression via modulating the miR-651-5p/BDNF axis.
Wang M; Han Z; Wang X; Cheng Y; Cao Z; Zhang Y; Zhang Y
Odontology; 2024 Feb; ():. PubMed ID: 38376795
[TBL] [Abstract][Full Text] [Related]
15. Silencing of long non-coding RNA NCK1-AS1 inhibits cell proliferation and migration via inhibition of microRNA-134 in cervical cancer.
Huang L; Gan X; He L; Wang L; Yu J
Exp Ther Med; 2019 Sep; 18(3):2314-2322. PubMed ID: 31410182
[TBL] [Abstract][Full Text] [Related]
16. AS1 expression in prostate cancer and its effects on proliferation and invasion of prostate cancer cells.
Li Y; Zhuang X; Zhuang L; Liu H
Cancer Biomark; 2021; 32(3):271-279. PubMed ID: 34151833
[TBL] [Abstract][Full Text] [Related]
17. LncRNA MCM3AP-AS1 promotes proliferation, migration and invasion of oral squamous cell carcinoma cells via regulating miR-204-5p/FOXC1.
Li H; Jiang J
J Investig Med; 2020 Oct; 68(7):1282-1288. PubMed ID: 32690597
[TBL] [Abstract][Full Text] [Related]
18. LncRNA NCK1-AS1 promotes proliferation and induces cell cycle progression by crosstalk NCK1-AS1/miR-6857/CDK1 pathway.
Li H; Jia Y; Cheng J; Liu G; Song F
Cell Death Dis; 2018 Feb; 9(2):198. PubMed ID: 29416014
[TBL] [Abstract][Full Text] [Related]
19. Suppression of long noncoding RNA NCK1-AS1 increases chemosensitivity to cisplatin in cervical cancer.
Zhang WY; Liu YJ; He Y; Chen P
J Cell Physiol; 2019 Apr; 234(4):4302-4313. PubMed ID: 30221354
[TBL] [Abstract][Full Text] [Related]
20. Exosomal LncRNA LBX1-AS1 Derived From RBPJ Overexpressed-Macrophages Inhibits Oral Squamous Cell Carcinoma Progress
Ai Y; Wei H; Wu S; Tang Z; Li X; Zou C
Front Oncol; 2021; 11():605884. PubMed ID: 33816238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
